Absorption |
Blood-Brain Barrier | BBB- | 0.9916 |
Human Intestinal Absorption | HIA+ | 0.6112 |
Caco-2 Permeability | Caco2+ | 0.5859 |
P-glycoprotein Substrate | Substrate | 0.6099 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8604 |
Non-inhibitor | 0.9967 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9576 |
Distribution |
Subcellular localization | Lysosome | 0.6449 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8941 |
CYP450 2D6 Substrate | Non-substrate | 0.8509 |
CYP450 3A4 Substrate | Non-substrate | 0.5721 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7960 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9540 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9993 |
Non-inhibitor | 0.8531 |
AMES Toxicity | Non AMES toxic | 0.8334 |
Carcinogens | Non-carcinogens | 0.6384 |
Fish Toxicity | High FHMT | 0.9928 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9696 |
Honey Bee Toxicity | Low HBT | 0.5577 |
Biodegradation | Not ready biodegradable | 0.9843 |
Acute Oral Toxicity | IV | 0.4392 |
Carcinogenicity (Three-class) | Non-required | 0.6490 |